Potential clinical applications for human pluripotent stem cell-derived blood components

Stem Cells International

Volumn , Issue , 2011, Pages

  Lu, Shi Jiang ^a   Kimbrel, Erin A ^a  

^a Stem Cell and Regenerative Medicine International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ADULT STEM CELL; ANEMIA; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BLEEDING; BLOOD CLOTTING; BLOOD COMPONENT; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; EMBRYONIC STEM CELL; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; GRANULOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; IN VITRO STUDY; LEUKOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; NONHUMAN; OXYGEN TRANSPORT; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL DERIVED BLOOD COMPONENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REGENERATIVE MEDICINE; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 79959480335     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.4061/2011/273076     Document Type: Review

References (83)

1. Menendez P., Bueno C., Wang L., Bhatia M., Human embryonic stem cells: potential tool for achieving immunotolerance? Stem Cell Reviews 2005 1 2 151 158 (Pubitemid 43074200)
2. Fairchild P. J., The challenge of immunogenicity in the quest for induced pluripotency Nature Reviews Immunology 2010 10 12 868 875
3. Zhu J., Emerson S. G., Hematopoietic cytokines, transcription factors and lineage commitment Oncogene 2002 21 21 3295 3313 (Pubitemid 34587705)
4. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P., Histology: The Lives and Deaths of Cells in Tissues (Table 22-1) in Molecular Biology of the Cell 2002 New York, NY, USA Garland Science
5. Dean L., Blood Groups and Red Cell Antigens 2005 Bethesda, Md, USA NCBI
6. Whitaker B. I., Henry R., Nationwide blood collection and utilization survey Report 12-31-2007 Advancing Transfusion and Cellular Therapies Worldwide
7. Palis J., Ontogeny of erythropoiesis Current Opinion in Hematology 2008 15 3 155 161 (Pubitemid 351507565)
8. Giarratana M. C., Kobari L., Lapillonne H., Chalmers D., Kiger L., Cynober T., Marden M. C., Wajcman H., Douay L., Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells Nature Biotechnology 2005 23 1 69 74 (Pubitemid 41724627)
9. Miharada K., Hiroyama T., Sudo K., Nagasawa T., Nakamura Y., Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells Nature Biotechnology 2006 24 10 1255 1256 (Pubitemid 44564771)
10. Chang K. H., Nelson A. M., Cao H., Wang L., Nakamoto B., Ware C. B., Papayannopoulou T., Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin Blood 2006 108 5 1515 1523 (Pubitemid 44316116)
11. Olivier E. N., Qiu C., Velho M., Hirsch R. E., Bouhassira E. E., Large-scale production of embryonic red blood cells from human embryonic stem cells Experimental Hematology 2006 34 12 1635 1642 (Pubitemid 44838996)
12. Lu S. J., Feng Q., Caballero S., Chen YU., Moore M. A. S., Grant M. B., Lanza R., Generation of functional hemangioblasts from human embryonic stem cells Nature Methods 2007 4 6 501 509 (Pubitemid 46852076)
13. Lu S. J., Luo C., Holton K., Feng Q., Ivanova Y., Lanza R., Robust generation of hemangioblastic progenitors from human embryonic stem cells Regenerative Medicine 2008 3 5 693 704
14. Lu S. J., Feng Q., Park J. S., Vida L., Lee B. S., Strausbauch M., Wettstein P. J., Honig G. R., Lanza R., Biologic properties and enucleation of red blood cells from human embryonic stem cells Blood 2008 112 12 4475 4484
15. Choi K. D., Yu J., Smuga-Otto K., Salvagiotto G., Rehrauer W., Vodyanik M., Thomson J., Slukvin I., Hematopoietic and endothelial differentiation of human induced pluripotent stem cells Stem Cells 2009 27 3 559 567
16. Ye Z., Zhan H., Mali P., Dowey S., Williams D. M., Jang Y. Y., Dang C. V., Spivak J. L., Moliterno A. R., Cheng L., Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood 2009 114 27 5473 5480
17. Lengerke C., Grauer M., Niebuhr N. I., Riedt T., Kanz L., Park IN. H., Daley G. Q., Hematopoietic development from human induced pluripotent stem cells Annals of the New York Academy of Sciences 2009 1176 219 227
18. Feng Q., Lu S. J., Klimanskaya I., Gomes I., Kim D., Chung Y., Honig G. R., Kim K. S., Lanza R., Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence Stem Cells 2010 28 4 704 712
19. Szabo E., Rampalli S., Risueo R. M., Schnerch A., Mitchell R., Fiebig-Comyn A., Levadoux-Martin M., Bhatia M., Direct conversion of human fibroblasts to multilineage blood progenitors Nature 2010 468 7323 521 526
20. Slichter S. J., Relationship between platelet count and bleeding risk in thrombocytopenic patients Transfusion Medicine Reviews 2004 18 3 153 167 (Pubitemid 38962484)
21. Tomer A., Human marrow megakaryocyte differentiation: multiparameter correlative analysis identifies von Willebrand factor as a sensitive and distinctive marker for early (2N and 4N) megakaryocytes Blood 2004 104 9 2722 2727 (Pubitemid 39434953)
22. Lordier L., Jalil A., Aurade F., Larbret F., Larghero J., Debili N., Vainchenker W., Chang Y., Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling Blood 2008 112 8 3164 3174
23. Reems J. A., Pineault N., Sun S., In vitro megakaryocyte production and platelet biogenesis: state of the art Transfusion Medicine Reviews 2010 24 1 33 43
24. Choi E. S., Nichol J. L., Hokom M. M., Hornkohl A. C., Hunt P., Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional Blood 1995 85 2 402 413
25. Norol F., Vitrat N., Cramer E., Guichard J., Burstein S. A., Vainchenker W., Debili N., Effects of cytokines on platelet production from blood and marrow CD34 + cells Blood 1998 91 3 830 843 (Pubitemid 28078285)
26. Bruno S., Gunetti M., Gammaitoni L., Dan A., Cavalloni G., Sanavio F., Fagioli F., Aglietta M., Piacibello W., In vitro and in vivo megakaryocyte differentiation of fresh and ex vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution Haematologica 2003 88 4 379 387 (Pubitemid 36547123)
27. Ungerer M., Peluso M., Gillitzer A., Massberg S., Heinzmann U., Schulz C., Mnch G., Gawaz M., Generation of functional culture-derived platelets from CD34 + progenitor cells to study transgenes in the platelet environment Circulation research 2004 95 5 e36 44
28. Sullenbarger B., Bahng J. H., Gruner R., Kotov N., Lasky L. C., Prolonged continuous in vitro human platelet production using three-dimensional scaffolds Experimental Hematology 2009 37 1 101 110
29. Gaur M., Kamata T., Wang S., Moran B., Shattil S. J., Leavitt A. D., Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function Journal of Thrombosis and Haemostasis 2006 4 2 436 442
30. Takayama N., Nishikii H., Usui J., Tsukui H., Sawaguchi A., Hiroyama T., Eto K., Nakauchi H., Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors Blood 2008 111 11 5298 5306
31. Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., Yamaguchi T., Otsu M., Nishimura K., Nakanishi M., Sawaguchi A., Nagai R., Takahashi K., Yamanaka S., Nakauchi H., Eto K., Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells Journal of Experimental Medicine 2010 207 13 2817 2830
32. Lu S.-J., Li F., Yin H., Feng Q., Kimbrel E. A., Hahm E., Thon J. N., Wang W., Italiano J. E., Cho J., Lanza R., Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Research. 2011, In press
33. Andrews D. M., Maraskovsky E., Smyth M. J., Cancer vaccines for established cancer: how to make them better? Immunological Reviews 2008 222 1 242 255 (Pubitemid 351430374)
34. Palucka K., Ueno H., Fay J., Banchereau J., Harnessing dendritic cells to generate cancer vaccines Annals of the New York Academy of Sciences 2009 1174 88 98
35. Shortman K., Liu Y. J., Mouse and human dendritic cell subtypes Nature Reviews Immunology 2002 2 3 151 161 (Pubitemid 37336516)
36. Lechmann M., Zinser E., Golka A., Steinkasserer A., Role of CD83 in the immunomodulation of dendritic cells International Archives of Allergy and Immunology 2002 129 2 113 118 (Pubitemid 36158557)
37. Caux C., Massacrier C., Vanbervliet B., Dubois B., van Kooten C., Durand I., Banchereau J., Activation of human dendritic cells through CD40 cross-linking Journal of Experimental Medicine 1994 180 4 1263 1272 (Pubitemid 24289600)
38. Snchez-Snchez N., Riol-Blanco L., Rodrguez-Fernndez J. L., The multiple personalities of the chemokine receptor CCR7 in dendritic cells Journal of Immunology 2006 176 9 5153 5159
39. Nestle F. O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Medicine 1998 4 3 328 332 (Pubitemid 28144092)
40. Thurner B., Haendle I., Rder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., Von Den Driesch P., Brcker E. B., Steinman R. M., Enk A., Kmpgen E., Schuler G., Vaccination with mage-3A1 peptide-pulsed nature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma Journal of Experimental Medicine 1999 190 11 1669 1678 (Pubitemid 30002348)
41. Palucka A. K., Ueno H., Connolly J., Kerneis-Norvell F., Blanck J. P., Johnston D. A., Fay J., Banchereau J., Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8 + T-cell immunity Journal of Immunotherapy 2006 29 5 545 557 (Pubitemid 44395279)
42. Kantoff P. W., Higano C. S., Shore N. D., Berger E. R., Small E. J., Penson D. F., Redfern C. H., Ferrari A. C., Dreicer R., Sims R. B., Xu Y., Frohlich M. W., Schellhammer P. F., Sipuleucel-T immunotherapy for castration-resistant prostate cancer The New England Journal of Medicine 2010 363 5 411 422
43. Small E. J., Fratesi P., Reese D. M., Strang G., Laus R., Peshwa M. V., Valone F. H., Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells Journal of Clinical Oncology 2000 18 23 3894 3903
44. Timmerman L., Dendreon sets Provenge price at 93,000, says only 2000 people will get it in first year. Xconomy, Business + Technology in the Exponential Economy, 2010
45. Slukvin I. I., Vodyanik M. A., Thomson J. A., Gumenyuk M. E., Choi E. D., Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway Journal of Immunology 2006 176 5 2924 2932
46. Su Z., Frye C., Bae K. M., Kelley V., Vieweg J., Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions Clinical Cancer Research 2008 14 19 6207 6217
47. Tseng S. Y., Nishimoto K. P., Silk K. M., Majumdar A. S., Dawes G. N., Waldmann H., Fairchild P. J., Lebkowski J. S., Reddy A., Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells Regenerative Medicine 2009 4 4 513 526
48. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K. A., Maliszewski C., Shortman K., Cebon J., Maraskovsky E., Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E 2 regulates the migratory capacity of specific DC subsets Blood 2002 100 4 1362 1372 (Pubitemid 34864293)
49. Kaliriski P., Vieira P. L., Schuitemaker J. H. N., De Jong E. C., Kapsenberg M. L., Prostaglandin E 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer Blood 2001 97 11 3466 3469
50. Yokoyama W. M., Kim S., French A. R., The dynamic life of natural killer cells Annual Review of Immunology 2004 22 405 429 (Pubitemid 38680428)
51. Alici E., Sutlu T., Natural killer cell-based immunotherapy in cancer: current insights and future prospects Journal of Internal Medicine 2009 266 2 154 181
52. Cooper M. A., Cooper M. A., Fehniger T. A., Fehniger T. A., Caligiuri M. A., The biology of human natural killer-cell subsets Trends in Immunology 2001 22 11 633 640 (Pubitemid 33043908)
53. Caligiuri M. A., Human natural killer cells Blood 2008 112 3 461 469
54. Rosenberg S. A., Lotze M. T., Muul L. M., A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone The New England Journal of Medicine 1987 316 15 889 897 (Pubitemid 17041979)
55. Rosenberg S. A., Lotze M. T., Muul L. M., Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer The New England Journal of Medicine 1985 313 23 1485 1492 (Pubitemid 16212345)
56. Woll P. S., Martin C. H., Miller J. S., Kaufman D. S., Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity Journal of Immunology 2005 175 8 5095 5103 (Pubitemid 41456393)
57. Woll P. S., Grzywacz B., Tian X., Marcus R. K., Knorr D. A., Verneris M. R., Kaufman D. S., Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity Blood 2009 113 24 6094 6101
58. Ni Z., Knorr D. A., Clouser C. L., Hexum M. K., Southern P., Mansky L. M., Park I.-H., Kaufman D. S., Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms Journal of Virology 2011 85 1 43 50
59. Seder R. A., Ahmed R., Similarities and differences in CD4 + and CD8 + effector and memory T cell generation Nature Immunology 2003 4 9 835 842 (Pubitemid 37098653)
60. Mougiakakos D., Choudhury A., Lladser A., Kiessling R., Johansson C. C., Regulatory T cells in cancer Advances in Cancer Research 2010 107 57 117
61. Xiong N., Raulet D. H., Development and selection of T cells Immunological Reviews 2007 215 1 15 31
62. Godfrey D. I., Stankovic S., Baxter A. G., Raising the NKT cell family Nature Immunology 2010 11 3 197 206
63. Rosenberg S. A., Packard B. S., Aebersold P. M., Solomon D., Topalian S. L., Toy S. T., Simon P., Lotze M. T., Yang J. C., Seipp C. A., Simpson C., Carter C., Bock S., Schwartzentruber D., Wei J. P., White D. E., Use of tumor-infiltrating lymphocyts and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report The New England Journal of Medicine 1988 319 25 1676 1680 (Pubitemid 19015247)
64. Dudley M. E., Wunderlich J. R., Robbins P. F., Yang J. C., Hwu P., Schwartzentruber D. J., Topalian S. L., Sherry R., Restifo N. P., Hubicki A. M., Robinson M. R., Raffeld M., Duray P., Seipp C. A., Rogers-Freezer L., Morton K. E., Mavroukakis S. A., White D. E., Rosenberg S. A., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 2002 298 5594 850 854 (Pubitemid 35231542)
65. Dudley M. E., Wunderlich J. R., Yang J. C., Sherry R. M., Topalian S. L., Restifo N. P., Royal R. E., Kammula U., White D. E., Mavroukakis S. A., Rogers L. J., Gracia G. J., Jones S. A., Mangiameli D. P., Pelletier M. M., Gea-Banacloche J., Robinson M. R., Berman D. M., Filie A. C., Abati A., Rosenberg S. A., Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma Journal of Clinical Oncology 2005 23 10 2346 2357 (Pubitemid 46218728)
66. Rosenberg S. A., A new era for cancer immunotherapy based on the genes that encode cancer antigens Immunity 1999 10 3 281 287 (Pubitemid 29165283)
67. Mehta-Damani A., Markowicz S., Engleman E. G., Generation of antigen-specific CD8 + CTLs from naive precursors Journal of Immunology 1994 153 3 996 1003 (Pubitemid 24228491)
68. Mutis T., Ghoreschi K., Schrama E., Kamp J., Heemskerk M., Falkenburg J. H. F., Wilke M., Goulmy E., Efficient induction of minor histocompatibility antigen HA-I-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-I-coding cDNA Biology of Blood and Marrow Transplantation 2002 8 8 412 419
69. Hunder N. N., Wallen H., Cao J., Hendricks D. W., Reilly J. Z., Rodmyre R., Jungbluth A., Gnjatic S., Thompson J. A., Yee C., Treatment of metastatic melanoma with autologous CD4 + T cells against NY-ESO-1 The New England Journal of Medicine 2008 358 25 2698 2703 (Pubitemid 351860862)
70. Morgan R. A., Dudley M. E., Wunderlich J. R., Hughes M. S., Yang J. C., Sherry R. M., Royal R. E., Topalan S. L., Kammula U. S., Restifo N. P., Zheng Z., Nahvi A., De Vries C. R., Rogers-Freezer L. J., Mavroukakis S. A., Rosenberg S. A., Cancer regression in patients after transfer of genetically engineered lymphocytes Science 2006 314 5796 126 129 (Pubitemid 44547756)
71. Cohen C. J., Li Y. F., El-Gamil M., Robbins P. F., Rosenberg S. A., Morgan R. A., Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond Cancer Research 2007 67 8 3898 3903 (Pubitemid 46762178)
72. Kitchen S. G., Bennett M., Gali Z., Kim J., Xu Q., Young A., Lieberman A., Joseph A., Goldstein H., Ng H., Yang O., Zack J. A., Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice PloS One 2009 4 12, article e8208
73. Cooper L. J. N., Kalos M., Lewinsohn D. A., Riddell S. R., Greenberg P. D., Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes Journal of Virology 2000 74 17 8207 8212 (Pubitemid 30641669)
74. Jaleco A. C., Neves H., Hooijberg E., Gameiro P., Clode N., Haury M., Henrique D., Parreira L., Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation Journal of Experimental Medicine 2001 194 7 991 1001 (Pubitemid 32953267)
75. Awong G., Herer E., Surh C. D., Dick J. E., La Motte-Mohs R. N., Ziga-Pflcker J. C., Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells Blood 2009 114 5 972 982
76. Benne C., Lelievre J. D., Balbo M., Henry A., Sakano S., Levy Y., Notch increases T/NK potential of human hematopoietic progenitors and inhibits B cell differentiation at a pro-B stage Stem Cells 2009 27 7 1676 1685
77. Gali Z., Kitchen S. G., Kacena A., Subramanian A., Burke B., Cortado R., Zack J. A., T lineage differentiation from human embryonic stem cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 31 11742 11747 (Pubitemid 44182521)
78. Gali Z., Kitchen S. G., Subramanian A., Bristol G., Marsden M. D., Balamurugan A., Kacena A., Yang O., Zack J. A., Generation of T lineage cells from human embryonic stem cells in a feeder free system Stem Cells 2009 27 1 100 107
79. Timmermans F., Velghe I., Vanwalleghem L., De Smedt M., van Coppernolle S., Taghon T., Moore H. D., Leclercq G., Langerak A. W., Kerre T., Plum J., Vandekerckhove B., Generation of T cells from human embryonic stem cell-derived hematopoietic zones Journal of Immunology 2009 182 11 6879 6888
80. Vodyanik M. A., Bork J. A., Thomson J. A., Slukvin I. I., Human embryonic stem cell-derived CD34 + cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential Blood 2005 105 2 617 626 (Pubitemid 40070744)
81. Atallah E., Schiffer C. A., Granulocyte transfusion Current Opinion in Hematology 2006 13 1 45 49
82. Saeki K., Saeki K., Nakahara M., Matsuyama S., Nakamura N., Yogiashi Y., Yoneda A., Koyanagi M., Kondo Y., Yuo A., A feeder-free and efficient production of functional neutrophils from human embryonic stem cells Stem Cells 2009 27 1 59 67
83. Yokoyama Y., Suzuki T., Sakata-Yanagimoto M., Kumano K., Higashi K., Takato T., Kurokawa M., Ogawa S., Chiba S., Derivation of functional mature neutrophils from human embryonic stem cells Blood 2009 113 26 6584 6592